Director of the Hematology Laboratory, AHEPA University Hospital, Greece
Dr. Panagiota Tsiatsiou is a distinguished medical biopathologist with over two decades of extensive experience in clinical microbiology and hematology diagnostics. She currently serves as the Director of the Hematology Section at AHEPA University Hospital in Thessaloniki, Greece. Renowned for her dedication to precision medicine, she has played a pivotal role in modernizing hematological laboratory protocols, especially during the COVID-19 pandemic. Her expertise spans molecular diagnostics, hemoglobinopathies, and hemostasis, and she actively mentors future medical biopathologists through structured clinical training programs. 🏥🧬📊
Professional Profile
Scopus
Orcid
🎓 Education
Dr. Tsiatsiou received her M.D. from the School of Health Sciences at Aristotle University of Thessaloniki (1988–1995). She completed her rural medical service in Evros (1996–1997) and specialized in Medical Biopathology at Theageneio Anticancer Hospital of Thessaloniki (1997–2002), earning board certification in 2002. 📚👩🔬 She holds three master’s degrees: in Health Services Management (Hellenic Open University), Public Health (National School of Public Health), and Biomedical Sciences in Diagnosis and Therapy (Democritus University of Thrace & IHU), each supported by robust thesis research on blood donor psychology, foodborne infections, and FV Leiden mutations respectively. 📖🔍🧪
💼 Experience
From 2003 to 2020, Dr. Tsiatsiou held various laboratory positions within Greece’s National Health System, contributing to critical microbiological investigations. Since 2011, she has worked at AHEPA University Hospital, where she was appointed Director of the Hematology Section in 2018. 🏥💉 Her primary responsibilities include the diagnostic evaluation of hemoglobinopathies, coagulation disorders, and molecular hematology. She also oversees training programs for medical residents and was instrumental in managing laboratory diagnostics for COVID-19 hemostasis complications. 🔬🦠📈
🔬 Research Interests
Her research interests lie in hematological molecular diagnostics, hemoglobinopathy prevalence, and biomarkers in infectious diseases, particularly in the context of COVID-19. She is deeply involved in translational research, focusing on the role of angiopoietins and genetic mutations such as FV Leiden in disease prognosis and diagnostics. 🧬🩸📊 Her work aims to bridge clinical application and molecular understanding, particularly in the domains of public health risk profiling and diagnostic accuracy.
🏆 Awards
While specific awards were not enumerated, Dr. Tsiatsiou’s sustained leadership, scientific output, and her appointment as Director of a major hematology unit underscore her professional excellence. 🏆📜 Her postgraduate honors and impactful roles during the COVID-19 crisis speak to a career rooted in public service, scientific integrity, and innovation in diagnostic science. 🌟🔖👩⚕️
📚 Top Noted Publications
Tsiatsiou, P. (2024). Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves, Current Issues in Molecular Biology.
🔗 Read the Article – Published in 2024, Current Issues in Molecular Biology – Cited in ongoing research evaluating COVID-19 biomarkers.
Conclusion
Dr. Panagiota Tsiatsiou is a highly suitable candidate for the Best Researcher Award, particularly in fields of Medical Biopathology, Hematology Diagnostics, and Public Health Research. Her academic rigor, clinical leadership, and contributions to health systems resilience during the COVID-19 pandemic distinguish her as a multidisciplinary expert and public health advocate. With further emphasis on international collaboration and high-impact publishing, her research legacy will continue to grow. She is both a deserving nominee and a role model for future medical scientists. 🌟🔬🥇